Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|November 14, 1997
Tobramycin population pharmacokinetics in neonatesM de Hoog, R C Schoemaker, J W Mouton, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Vancomycin population pharmacokinetics in neonatesM de Hoog, R C Schoemaker, J W Mouton, et al.
Tijdschrift Voor Kindergeneeskunde|February 1, 1993
[Application of non-glycoside inotropic agents in newborn infants]M A Umans-Eckenhausen, J F Terlouw, A Szatmari, et al.
Clinical Pharmacokinetics|July 31, 1999
Glucuronidation in humans. Pharmacogenetic and developmental aspectsS N de Wildt, G L Kearns, J S Leeder, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 5, 2002
Lack of effect of the European guidance on clinical investigation of medicines in childrenG W 't Jong, B H Ch Stricker, I Choonar, et al.
British Journal of Haematology|July 1, 1994
A case of severe neonatal thrombocytopenia with schizencephaly associated with anti-HPA-1b and anti-HPA-2aR W Kuijpers, J N van den Anker, W Baerts, et al.
Pediatric Radiology|January 1, 1992
Iatrogenic perforation of the lamina cribrosa by nasogastric tube in an infantJ N van den Anker, W Baerts, J M Quak, et al.
Critical Care Medicine|June 1, 1997
Variation of inhaled nitric oxide concentration with the use of a continuous flow ventilatorA P De Jaegere, F I Jacobs, N G Laheij, et al.
Clinical Pharmacokinetics|January 11, 2000
Cytochrome P450 3A: ontogeny and drug dispositionS N de Wildt, G L Kearns, J S Leeder, et al.
Clinical Pharmacology and Therapeutics|October 24, 2001
Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosusB Van Overmeire, D Touw, P J Schepens, et al.
Pageof 7